129 related articles for article (PubMed ID: 25636303)
1. Rapid dissolution of propofol emulsions under sink conditions.
Damitz R; Chauhan A
Int J Pharm; 2015 Mar; 481(1-2):47-55. PubMed ID: 25636303
[TBL] [Abstract][Full Text] [Related]
2. Physical properties and stability of two emulsion formulations of propofol.
Han J; Davis SS; Washington C
Int J Pharm; 2001 Mar; 215(1-2):207-20. PubMed ID: 11250106
[TBL] [Abstract][Full Text] [Related]
3. "Micro to macro (M2M)"--A novel approach for intravenous delivery of propofol.
Damitz R; Chauhan A
Int J Pharm; 2015 Oct; 494(1):218-26. PubMed ID: 26260228
[TBL] [Abstract][Full Text] [Related]
4. Kinetically stable propofol emulsions with reduced free drug concentration for intravenous delivery.
Damitz R; Chauhan A
Int J Pharm; 2015; 486(1-2):232-41. PubMed ID: 25839419
[TBL] [Abstract][Full Text] [Related]
5. The effect of lidocaine on the globule size distribution of propofol emulsions.
Park JW; Park ES; Chi SC; Kil HY; Lee KH
Anesth Analg; 2003 Sep; 97(3):769-771. PubMed ID: 12933399
[TBL] [Abstract][Full Text] [Related]
6. Free radical and drug oxidation products in an intensive care unit sedative: propofol with sulfite.
Baker MT; Gregerson MS; Martin SM; Buettner GR
Crit Care Med; 2003 Mar; 31(3):787-92. PubMed ID: 12626985
[TBL] [Abstract][Full Text] [Related]
7. A propofol microemulsion with low free propofol in the aqueous phase: formulation, physicochemical characterization, stability and pharmacokinetics.
Cai W; Deng W; Yang H; Chen X; Jin F
Int J Pharm; 2012 Oct; 436(1-2):536-44. PubMed ID: 22814221
[TBL] [Abstract][Full Text] [Related]
8. The effect of nimodipine, fentanyl and remifentanil intravenous products on the stability of propofol emulsions.
Nemec K; Germ E; Schulz-Siegmund M; Ortner A
Pharmazie; 2009 Feb; 64(2):94-7. PubMed ID: 19320281
[TBL] [Abstract][Full Text] [Related]
9. In vitro release of propofol and binding capacity with regard to plasma constituents.
Schicher M; Polsinger M; Hermetter A; Prassl R; Zimmer A
Eur J Pharm Biopharm; 2008 Nov; 70(3):882-8. PubMed ID: 18640268
[TBL] [Abstract][Full Text] [Related]
10. Physical and Chemical Compatibility of Etomidate and Propofol Injectable Emulsions.
Wang C; Wang S; Wu C; Lei L; Wang DX; Zhang Q
Pharmacology; 2021; 106(11-12):644-657. PubMed ID: 34644710
[TBL] [Abstract][Full Text] [Related]
11. A continuous flow method for estimation of drug release rates from emulsion formulations.
Salmela L; Washington C
Int J Pharm; 2014 Sep; 472(1-2):276-81. PubMed ID: 24945139
[TBL] [Abstract][Full Text] [Related]
12. Propofol emulsion-free drug concentration is similar between batches and stable over time.
Damitz R; Chauhan A; Gravenstein N
Rom J Anaesth Intensive Care; 2016 Apr; 23(1):7-11. PubMed ID: 28913471
[TBL] [Abstract][Full Text] [Related]
13. New drug, fospropofol disodium: a propofol prodrug.
Welliver M; Rugari SM
AANA J; 2009 Aug; 77(4):301-8. PubMed ID: 19731849
[TBL] [Abstract][Full Text] [Related]
14. Propofol ('Diprivan') emulsion for total intravenous anaesthesia.
de Grood PM; Ruys AH; van Egmond J; Booij LH; Crul JF
Postgrad Med J; 1985; 61 Suppl 3():65-9. PubMed ID: 3877298
[TBL] [Abstract][Full Text] [Related]
15. Effect of syringe filter and i.v. administration set on delivery of propofol emulsion.
Bailey LC; Tang KT; Rogozinski BA
Am J Hosp Pharm; 1991 Dec; 48(12):2627-30. PubMed ID: 1814205
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of new propofol aqueous solutions for intravenous anesthesia.
Trapani A; Laquintana V; Lopedota A; Franco M; Latrofa A; Talani G; Sanna E; Trapani G; Liso G
Int J Pharm; 2004 Jun; 278(1):91-8. PubMed ID: 15158952
[TBL] [Abstract][Full Text] [Related]
17. Propofol (Diprivan®) and Intralipid® exacerbate insulin resistance in type-2 diabetic hearts by impairing GLUT4 trafficking.
Lou PH; Lucchinetti E; Zhang L; Affolter A; Gandhi M; Zhakupova A; Hersberger M; Hornemann T; Clanachan AS; Zaugg M
Anesth Analg; 2015 Feb; 120(2):329-40. PubMed ID: 25437926
[TBL] [Abstract][Full Text] [Related]
18. Effect of Lipid Composition in Propofol Formulations: Decisive Component in Reducing the Free Propofol Content and Improving Pharmacodynamic Profiles.
Darandale SS; Shevalkar GB; Vavia PR
AAPS PharmSciTech; 2017 Feb; 18(2):441-450. PubMed ID: 27055535
[TBL] [Abstract][Full Text] [Related]
19. The effect of the addition of lignocaine on propofol emulsion stability.
Lilley EM; Isert PR; Carasso ML; Kennedy RA
Anaesthesia; 1996 Sep; 51(9):815-8. PubMed ID: 8882240
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of propofol microemulsion and lipid emulsion after an intravenous bolus and variable rate infusion.
Kim KM; Choi BM; Park SW; Lee SH; Christensen LV; Zhou J; Yoo BH; Shin HW; Bae KS; Kern SE; Kang SH; Noh GJ
Anesthesiology; 2007 May; 106(5):924-34. PubMed ID: 17457123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
